Project summary
Smarter and smaller radiotherapy systems for treating cancer.
What is the issue?
The Nano-X Latus device is an innovative Australian-designed and developed cancer treatment system changing the delivery of radiation therapy. Its advanced on-board system captures 3D images in real-time and uses that information to deliver the correct amount of radiation automatically to the cancerous tissue. Nano-X Latus is smarter and smaller than its competitors with smaller capital, operational and staffing overheads.
What does the technology aim to do?
Nano-X is an Australian medtech company building novel radiotherapy systems for treating cancer. The Nano- X Latus device enables affordable, precision radiotherapy treatments to be decentralised and accessible in resource limited locations where the large capital and operational costs and high staff-to patient ratios of conventional radiotherapy systems limit their utilisation.
Nano-X leverages real-time radiotherapy at the core of its devices to deliver world leading clinical precision radiotherapy. This technology has been developed in partnership with The University of Sydney and has demonstrated superior cancer targeting accuracy, reduced treatment margins, better tumour dose coverage and lower toxicity.
Nano-X is a portfolio company of ATP Innovations.
Company contact
Dr Ilana Feain, Founder & CEO
ilana.feain@nano-x.com.au
www.nano-x.com.au
+61 2 9209 4444
Milestones